Statin Therapy In Patients With Vasospastic Angina

NCT02790528 · Status: WITHDRAWN · Phase: PHASE4 · Type: INTERVENTIONAL

Last updated 2017-06-15

No results posted yet for this study

Summary

The purpose of this study is to evaluate whether statin is effective in the treatment of vasospastic angina.

Conditions

  • Angina Pectoris, Variant
  • Statins, HMG-CoA

Interventions

DRUG

Atorvastatin

20mg QD

DRUG

Placebo

Placebo drug will be administered.

Sponsors & Collaborators

  • CardioVascular Research Foundation, Korea

    collaborator OTHER
  • Seung-Jung Park

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-07-31
Primary Completion
2023-06-30
Completion
2023-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02790528 on ClinicalTrials.gov